Enzyme Stabilizer Market Report 2026

The enzyme stabilizer market size has grown strongly in recent years. It will grow from $3.61 billion in 2025 to $3.86 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to expansion of enzyme-based industrial processes, growth in detergent and food enzyme usage, increased adoption in pharmaceuticals, availability of stabilizing compounds, rising focus on product quality.

The enzyme stabilizer market size is expected to see strong growth in the next few years. It will grow to $5 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for specialty enzymes, expansion of biopharmaceutical manufacturing, growing focus on sustainable bio-based processes, rising investments in enzyme engineering, increasing adoption in advanced food processing. Major trends in the forecast period include increasing demand for enhanced enzyme shelf stability, rising use in industrial biotechnology applications, growing focus on temperature and ph resistance, expansion of encapsulation technologies, enhanced optimization of enzyme performance.

The increasing demand for processed foods is projected to drive the growth of the enzyme stabilizer market in the future. Processed foods refer to items that have undergone transformation from their natural state through methods such as canning, freezing, and the addition of preservatives. This rising demand is primarily due to the need for convenience, longer shelf life, and the fast-paced lifestyles of consumers. Enzyme stabilizers play a crucial role in processed foods by preserving enzyme activity during both manufacturing and storage, which ensures product consistency and enhances shelf life. For example, the United States Department of Agriculture reported that the total value of processed food products exported from the U.S. reached $36.59 billion in 2023, marking a 1.7% increase from previous years. Consequently, the growing appetite for processed foods is fueling the enzyme stabilizer market's expansion.

Leading companies in the enzyme stabilizer market are dedicated to creating innovative solutions, including oral enzyme stabilizers, to improve efficacy and user convenience. Oral enzyme stabilizers are substances designed to protect enzymes as they traverse the gastrointestinal tract, maintaining their effectiveness for therapeutic and digestive applications. For instance, in June 2023, Amicus Therapeutics, a biotechnology firm based in the U.S., received approval from the European Commission for opfolda (miglustat) 65 mg capsules. This enzyme stabilizer is used with cipaglucosidase alfa in long-term enzyme replacement therapy for adults suffering from late-onset Pompe disease, making it a vital part of their treatment regimen.

In November 2023, Biocatalysts Ltd., a U.S.-based company that specializes in the development and manufacturing of specialty enzymes, acquired Breatec, WeissBioTech, and Biosun from Brain Biotech AG for an undisclosed sum. This acquisition allows Biocatalysts to enhance its synergies within the BRAIN group and reinforces its commitment to significant growth in its core markets of Europe and North America. Breatec, located in the Netherlands, focuses on developing optimized enzymes and biocatalysts, while WeissBioTech GmbH, based in Germany, provides tailored ready-to-use enzymes for the food and beverage industries. Biosun, also located in Germany, specializes in food ingredients, including flavors, enzymes, and natural colors.

Major companies operating in the enzyme stabilizer market are Novozymes A/S, DSM-Firmenich N.V., DuPont de Nemours Inc., BASF SE, Kerry Group plc, Chr. Hansen Holding A/S, AB Enzymes GmbH, Amano Enzyme Inc., Biocatalysts Ltd., Codexis Inc., Specialty Enzymes and Probiotics LLC, Dyadic International Inc., Megazyme Ltd., Enzyme Innovation Inc., Maps Enzymes Ltd., Laffort SA, Sorachim SA, Creative Enzymes Inc., Advanced Enzyme Technologies Ltd., Sunson Industry Group Co. Ltd., Jiangsu Boli Bioproducts Co. Ltd., Enzymatic Solutions Inc., Aumgene Biosciences Inc.

North America was the largest region in the enzyme stabilizer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme stabilizer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enzyme stabilizer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme stabilizer market consists of sales of chelating agents, organic solvents, mannitol, and sorbitol. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.